Our Board and Network

Mike Aspinwall, Chief Executive Officer and Co-founder

For 30 years, Mike has helped build and grow innovative healthcare services companies, including Vantage Oncology, Bravo Health, and Paradigm Health, as a hands-on investor and executive. Before co-founding Stability Health, Mike was a managing partner with responsibility for all healthcare investing at CCP Equity Partners, and co-head of the healthcare sector at GE Equity. In these two positions, he successfully invested over $170 million in over a dozen companies.

Mike’s dad lived with type 1 diabetes for 60 years, and this has motivated him to start Stability Health. Through this first-hand experience he saw both the challenges and successes which come with managing diabetes proactively

Dave Harlan, Chief Scientific Officer and Co-founder

As an American Board of Internal Medicine certified endocrinologist, Dave has spent his 39-year professional career practicing and promoting innovative care for people with diabetes in various capacities. He received his medical training at Duke and then spent the first 30 years in the US Navy, and later, the US Public Health Service, attaining the rank of Captain in both. Since 2010, he has served as Co-Director of the University of Massachusetts Medical School/UMass Memorial Health Care (UMMS/UMMHC) Diabetes Center of Excellence. While assigned at the National Institutes of Health (NIH), Dave conducted internationally-recognized efforts exploring transplantation-based therapies for diabetes, among other things.

His motivation for co-founding Stability Health is rooted in his steadfast belief that the standard of diabetes care could be, and should be, improved dramatically.

Roy Beveridge, MD , Director

Roy is a medical oncologist who has been in practice for over 20 years. He most recently served as Humana’s Chief Medical Officer where he led health policy and clinical quality initiatives. Roy has held similar roles for US Oncology and McKesson specialty solutions. He has authored over 200 papers, with much of his recent work focused on social determinants of health and improving the health of underserved populations.

Mike Fiore, Director and Investor

Mike is a veteran healthcare services executive who has spent the last thirty-seven years in physician-driven businesses. He was Co-founder and CEO of Vantage Oncology, a developer and operator of multi-specialty oncology treatment centers and a cancer care management company until McKesson acquired the business in 2016.

Steve Gruber, Director and Investor

Steve is an Advisory Managing Partner and Co-Founder of Oak Hill Capital Partners. He was formerly a Managing Partner and has been a part of the firm since 1990. Over the last 30 years, Steve has served on approximately 40 corporate boards, many of which have been in the health care and insurance sectors.

Our Network

Our $2.5 million seed round was funded by over 30 individuals, many of whom are successful healthcare executives and healthcare investors. Collectively, this group has over 500 years of healthcare related experience.